Nanomedicine-based strategy enhances anti-PD1 therapy to eradicate PTEN-negative GBM
A nanomedicine-based strategy for chemo-immunotherapy (CIT) of glioblastoma (GBM), which has the worst prognosis among brain tumors, was successfully developed.
More... |
All times are GMT -7. The time now is 04:40 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021